1. Home
  2. ABBV vs XOM Comparison

ABBV vs XOM Comparison

Compare ABBV & XOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABBV
  • XOM
  • Stock Information
  • Founded
  • ABBV 2012
  • XOM 1870
  • Country
  • ABBV United States
  • XOM United States
  • Employees
  • ABBV N/A
  • XOM N/A
  • Industry
  • ABBV Biotechnology: Pharmaceutical Preparations
  • XOM Integrated oil Companies
  • Sector
  • ABBV Health Care
  • XOM Energy
  • Exchange
  • ABBV Nasdaq
  • XOM Nasdaq
  • Market Cap
  • ABBV 403.2B
  • XOM 480.5B
  • IPO Year
  • ABBV N/A
  • XOM N/A
  • Fundamental
  • Price
  • ABBV $227.90
  • XOM $115.53
  • Analyst Decision
  • ABBV Buy
  • XOM Buy
  • Analyst Count
  • ABBV 21
  • XOM 16
  • Target Price
  • ABBV $233.74
  • XOM $127.06
  • AVG Volume (30 Days)
  • ABBV 6.2M
  • XOM 12.8M
  • Earning Date
  • ABBV 10-31-2025
  • XOM 10-31-2025
  • Dividend Yield
  • ABBV 2.88%
  • XOM 3.43%
  • EPS Growth
  • ABBV N/A
  • XOM N/A
  • EPS
  • ABBV 2.10
  • XOM 7.06
  • Revenue
  • ABBV $58,328,000,000.00
  • XOM $329,816,000,000.00
  • Revenue This Year
  • ABBV $9.86
  • XOM N/A
  • Revenue Next Year
  • ABBV $9.05
  • XOM N/A
  • P/E Ratio
  • ABBV $108.56
  • XOM $16.35
  • Revenue Growth
  • ABBV 6.05
  • XOM N/A
  • 52 Week Low
  • ABBV $163.81
  • XOM $97.80
  • 52 Week High
  • ABBV $244.81
  • XOM $123.21
  • Technical
  • Relative Strength Index (RSI)
  • ABBV 52.46
  • XOM 58.74
  • Support Level
  • ABBV $226.25
  • XOM $115.18
  • Resistance Level
  • ABBV $232.81
  • XOM $116.85
  • Average True Range (ATR)
  • ABBV 3.53
  • XOM 1.65
  • MACD
  • ABBV -1.08
  • XOM 0.28
  • Stochastic Oscillator
  • ABBV 41.45
  • XOM 79.58

About ABBV AbbVie Inc.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

About XOM Exxon Mobil Corporation

ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil worldwide. In 2024, it produced 3.0 million barrels of liquids and 8.1 billion cubic feet of natural gas per day. At the end of 2024, reserves were 19.9 billion barrels of oil equivalent, 69% of which were liquids. The company is one of the world's largest refiners, with a total global refining capacity of 4.3 million barrels of oil per day, and is one of the world's largest manufacturers of commodity and specialty chemicals.

Share on Social Networks: